OBJECTIVE: To compare the prevalence of metabolic abnormalities (MA) and metabolic syndrome (MS) assessed by different criteria among Brazilian adolescents. SUBJECTS AND METHODS: Weighted prevalence of MA and MS were estimated using criteria adapted from the International Diabetes Federation (IDF), National Cholesterol Education Program, Adult Treatment Panel III (NCEP/ATP III), and the World Health Organization (WHO) in a probabilistic sample of 577 students aged 12-19. RESULTS: The most prevalent MA was low concentration of HDL-C as per IDF (32.5%) and NCEP/ATP III (41.6%) criteria and hypertension as per the WHO's criterion (12.4%). Prevalence of MS using the NCEP/ATP III criterion (6.04%) was five times higher than the WHO's (1.1%) and the IDF's (1.6%) criteria. As expected, MS was significantly higher among overweight than among non-overweight adolescents. CONCLUSION: Low prevalence of MS but high prevalence of some MA were found. These findings suggest that the diagnosis of MA is more relevant in clinical practice especially in overweight adolescents.
OBJECTIVE: To compare the prevalence of metabolic abnormalities (MA) and metabolic syndrome (MS) assessed by different criteria among Brazilian adolescents. SUBJECTS AND METHODS: Weighted prevalence of MA and MS were estimated using criteria adapted from the International Diabetes Federation (IDF), National Cholesterol Education Program, Adult Treatment Panel III (NCEP/ATP III), and the World Health Organization (WHO) in a probabilistic sample of 577 students aged 12-19. RESULTS: The most prevalent MA was low concentration of HDL-C as per IDF (32.5%) and NCEP/ATP III (41.6%) criteria and hypertension as per the WHO's criterion (12.4%). Prevalence of MS using the NCEP/ATP III criterion (6.04%) was five times higher than the WHO's (1.1%) and the IDF's (1.6%) criteria. As expected, MS was significantly higher among overweight than among non-overweight adolescents. CONCLUSION: Low prevalence of MS but high prevalence of some MA were found. These findings suggest that the diagnosis of MA is more relevant in clinical practice especially in overweight adolescents.
Authors: Miguel Henrique Pereira de Paiva; Valberto Alencar Miranda Filho; Ana Raquel Soares de Oliveira; Kyria Jayanne Clímaco Cruz; Regina Maria Sousa de Araújo; Karla Andrade de Oliveira Journal: Rev Paul Pediatr Date: 2022-07-06
Authors: Maria Cristina C Kuschnir; Katia Vergetti Bloch; Moyses Szklo; Carlos Henrique Klein; Laura Augusta Barufaldi; Gabriela de Azevedo Abreu; Beatriz Schaan; Gloria Valeria da Veiga; Thiago Luiz Nogueira da Silva; Maurício T L de Vasconcellos; Ana Júlia Pantoja de Moraes; Ana Luíza Borges; Ana Mayra Andrade de Oliveira; Bruno Mendes Tavares; Cecília Lacroix de Oliveira; Cristiane de Freitas Cunha; Denise Tavares Giannini; Dilson Rodrigues Belfort; Eduardo Lima Santos; Elisa Brosina de Leon; Elizabeth Fujimori; Elizabete Regina Araújo Oliveira; Erika da Silva Magliano; Francisco de Assis Guedes Vasconcelos; George Dantas Azevedo; Gisela Soares Brunken; Isabel Cristina Britto Guimarães; José Rocha Faria Neto; Juliana Souza Oliveira; Kenia Mara B de Carvalho; Luis Gonzaga de Oliveira Gonçalves; Maria Inês Monteiro; Marize M Santos; Pascoal Torres Muniz; Paulo César B Veiga Jardim; Pedro Antônio Muniz Ferreira; Renan Magalhães Montenegro; Ricardo Queiroz Gurgel; Rodrigo Pinheiro Vianna; Sandra Mary Vasconcelos; Stella Maris Seixas Martins; Tamara Beres Lederer Goldberg Journal: Rev Saude Publica Date: 2016-02-23 Impact factor: 2.106
Authors: Marilia Brito Gomes; Deborah Conte; Karla Rezende Guerra Drummond; Felipe Mallmann; André Araújo Pinheiro; Franz Schubert Lopes Leal; Paulo Henrique Morales; Carlos Antonio Negrato Journal: Diabetol Metab Syndr Date: 2022-01-04 Impact factor: 3.320